Pharmaceutical Regulatory Services
Technical Writing
Medical Writing
RIMS Management
Data Governance & Regulatory Compliance
Regulatory Affairs Consulting
Regulatory Intelligence
Solving Biggest Challenges for Pharmaceutical Clients
Lack of specialized in-house resources
Challenge
Our SMEs provide value that cannot be achieved internally without huge investment in resources.
Our Approach
Complexity of global standards
and requirements
Challenge
Our technology enables us to adhere to complex region-specific requirement and maintain quality consistency.
Our Approach
Tight deadlines
Challenge
Where other providers struggle, we’re able to meet the toughest deadline. Our in-house Ai, automtion and template solutions relieve delivery teams from repetitive, time-consuming tasks.
Our Approach
Quality control
Challenge
Data is formatted, maintained, and secured thought out tech solutions, minimizing human error and improving data quality.
Our Approach
Regulatory Pharma Services for All Product Lifecycle Stages
Small Molecules
Biologics
Generics
Advanced Therapies
Biosimilars
Combination Products
CAPTIS® AI and Automation Technology
In-house AI-powered regulatory compliance technology, designed to streamline medical writing and documentation processes. CAPTIS® AI platform reduces manual effort, enhances regulatory accuracy, and creates effortless experiences for Celegence project teams and our customers.
eCTD viewer and dossier management
Our proprietary cloud-based dossier management solution eliminates manual steps in the exchange of regulatory dossiers. It allows you to share, view, and review eCTD, NeeS, and other dossier formats from any region and access them in any location with highest level of data protection.
eCTD-Ready Templates
Intuitive MS Word templates for eCTD-ready documents without software installation include stand-alone regulatory documents for, amongst others, NDA/BLA, IND, NDS, MAA, CTA, PIP, scientific advice, and briefing packages.
Celegence in-house technology for pharmaceutical support
-
50%
Faster delivery with intact quality
-
>95%
Improved accuracy over manual processes
-
30%
In saving against current operational cost
SME-DRIVEN EXPERTISE
- All our project leads have a Master's degree in a relevant field
- All have 10+ years of experience in Pharmaceutical Regulatory domain
- Experienced supporting regulatory strategy in 50+ countries
Based in the Netherlands, Maurice has over 27 years’ experience in the pharmaceutical and biotech industry, mainly supporting pre-approval drugs and biologics for oncology, pulmonary and cardiovascular indications, with extensive experience in developing regulatory strategies, leading cross-functional teams in health authority interactions (Scientific Advice, both on national and EU level) regulatory intelligence and applications including document development to support applications such as MAAs, CTAs, EU & US Orphan Drug Applications, PIPs, iPSPs, IND Annual Reports and DSURs. He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands. Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands.
Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
Read More
Read Less
With 20+ years of Pharmaceutical industry experience across Drug Discovery, Regulatory Affairs, and Compliance, Pradeep is a system and business process owner leading our Pharma division delivery teams. Pradeep holds a Master's degree in Biotechnology from Bangalore University.
- Established a Regulatory Operations team for Consumer Health business unit
- Spearheaded several RIM/eDMS and publishing system migrations
- Successfully managed xEVMPD integration into P&G Healthcare business unit
- Led business process harmonization and digitization activities for raw materials documentation and its compliance
- Co-chaired IDMP office
Read More
Read Less
Maikel Bouman is our Associate Director of Regulatory Operations and Publishing, with 8 years of industry experience.
He has broad subject matter expertise on the quality control of data, document publishing, planning/coordination, management, preparation/creation, and dispatch of different types of electronic submission formats to various regulatory authorities across the Americas, Europe and Australia.
Read More
Read Less
As a manager within Regulatory Data Management at Celegence, John has extensive experience in xEVMPD, IDMP, RIMS, and Regulatory Affairs.
John has supported numerous pharmaceutical companies in their digital transformations by selecting the right regulatory information management system, extracting & remediating regulatory data, reviewing and updating underlying processes, and fostering a culture of collaboration and innovation among teams to drive successful change.
Read More
Read Less
resources
Pharmaceutical
Ensuring Drug Product Integrity: Key Considerations from FDA’s Draft Guidance on 21 CFR 211.110
07 Jan, 2025
Pharmaceutical
Regulatory Submissions, Information, and Document Management Forum (RSIDMF) 2025
06 Jan, 2025
Pharmaceutical
Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions
28 Nov, 2024
Pharmaceutical
Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD
12 Nov, 2024
Pharmaceutical
Navigating Regulatory Challenges for Generic Inhalation Drug Products: A Strategic Approach
27 Mar, 2025
Pharmaceutical
Understanding the Critical Role of CMC Dossiers in Pharmaceutical Regulatory Submissions
24 Feb, 2025
Pharmaceutical
Overcoming Regulatory Challenges for Cell and Gene Therapy Products: Insights into ATMP Success
30 Jan, 2025
Pharmaceutical
Ensuring Drug Product Integrity: Key Considerations from FDA’s Draft Guidance on 21 CFR 211.110
07 Jan, 2025
Pharmaceutical
Regulatory Submissions, Information, and Document Management Forum (RSIDMF) 2025
06 Jan, 2025
Pharmaceutical
Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions
28 Nov, 2024
Pharmaceutical
Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD
12 Nov, 2024
Pharmaceutical
Navigating Regulatory Challenges for Generic Inhalation Drug Products: A Strategic Approach
27 Mar, 2025
Pharmaceutical
Understanding the Critical Role of CMC Dossiers in Pharmaceutical Regulatory Submissions
24 Feb, 2025
Pharmaceutical
Overcoming Regulatory Challenges for Cell and Gene Therapy Products: Insights into ATMP Success
30 Jan, 2025